NCT00426764 2020-02-11A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell LymphomaCelgenePhase 2 Completed131 enrolled 16 charts
NCT00106431 2019-10-30A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)CelgenePhase 2 Completed102 enrolled 15 charts